8 reports of this reaction
1.2% of all ASPIRIN AND CAFFEINE reports
#20 most reported adverse reaction
CHRONIC KIDNEY DISEASE is the #20 most commonly reported adverse reaction for ASPIRIN AND CAFFEINE, manufactured by Medtech Products Inc.. There are 8 FDA adverse event reports linking ASPIRIN AND CAFFEINE to CHRONIC KIDNEY DISEASE. This represents approximately 1.2% of all 684 adverse event reports for this drug.
Patients taking ASPIRIN AND CAFFEINE who experience chronic kidney disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CHRONIC KIDNEY DISEASE is a less commonly reported adverse event for ASPIRIN AND CAFFEINE, but still significant enough to appear in the safety profile.
In addition to chronic kidney disease, the following adverse reactions have been reported for ASPIRIN AND CAFFEINE:
The following drugs have also been linked to chronic kidney disease in FDA adverse event reports:
CHRONIC KIDNEY DISEASE has been reported as an adverse event in 8 FDA reports for ASPIRIN AND CAFFEINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CHRONIC KIDNEY DISEASE accounts for approximately 1.2% of all adverse event reports for ASPIRIN AND CAFFEINE, making it a notable side effect.
If you experience chronic kidney disease while taking ASPIRIN AND CAFFEINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.